1148 related articles for article (PubMed ID: 23586622)
1. Lipopolysaccharide of Aggregatibacter actinomycetemcomitans up-regulates inflammatory cytokines, prostaglandin E2 synthesis and osteoclast formation in interleukin-1 receptor antagonist-deficient mice.
Mizutani H; Ishihara Y; Izawa A; Fujihara Y; Kobayashi S; Gotou H; Okabe E; Takeda H; Ozawa Y; Kamiya Y; Kamei H; Kikuchi T; Yamamoto G; Mitani A; Nishihara T; Noguchi T
J Periodontal Res; 2013 Dec; 48(6):748-56. PubMed ID: 23586622
[TBL] [Abstract][Full Text] [Related]
2. Inflammatory bone loss in experimental periodontitis induced by Aggregatibacter actinomycetemcomitans in interleukin-1 receptor antagonist knockout mice.
Izawa A; Ishihara Y; Mizutani H; Kobayashi S; Goto H; Okabe E; Takeda H; Ozawa Y; Kamiya Y; Sugita Y; Kubo K; Kamei H; Kikuchi T; Mitani A; Hayashi J; Nishihara T; Maeda H; Noguchi T
Infect Immun; 2014 May; 82(5):1904-13. PubMed ID: 24566623
[TBL] [Abstract][Full Text] [Related]
3. FTY720 inhibited proinflammatory cytokine release and osteoclastogenesis induced by Aggregatibacter actinomycetemcomitans.
Yu H; Herbert BA; Valerio M; Yarborough L; Hsu LC; Argraves KM
Lipids Health Dis; 2015 Jul; 14():66. PubMed ID: 26138336
[TBL] [Abstract][Full Text] [Related]
4. Periodontal inflammation and alveolar bone loss induced by Aggregatibacter actinomycetemcomitans is attenuated in sphingosine kinase 1-deficient mice.
Yu H; Sun C; Argraves KM
J Periodontal Res; 2016 Feb; 51(1):38-49. PubMed ID: 25900155
[TBL] [Abstract][Full Text] [Related]
5. Oral administration of prostaglandin E(2)-specific receptor 4 antagonist inhibits lipopolysaccharide-induced osteoclastogenesis in rat periodontal tissue.
Oka H; Miyauchi M; Furusho H; Nishihara T; Takata T
J Periodontol; 2012 Apr; 83(4):506-13. PubMed ID: 21910594
[TBL] [Abstract][Full Text] [Related]
6. Involvement of prostaglandin E2 and interleukin-1 alpha in the differentiation and survival of osteoclasts induced by lipopolysaccharide from Actinobacillus actinomycetemcomitans Y4.
Ueda N; Koide M; Ohguchi M; Ishihara Y; Noguchi T; Okahashi N; Nishihara T
J Periodontal Res; 1998 Nov; 33(8):509-16. PubMed ID: 9879525
[TBL] [Abstract][Full Text] [Related]
7. Crucial involvement of the EP4 subtype of prostaglandin E receptor in osteoclast formation by proinflammatory cytokines and lipopolysaccharide.
Sakuma Y; Tanaka K; Suda M; Yasoda A; Natsui K; Tanaka I; Ushikubi F; Narumiya S; Segi E; Sugimoto Y; Ichikawa A; Nakao K
J Bone Miner Res; 2000 Feb; 15(2):218-27. PubMed ID: 10703923
[TBL] [Abstract][Full Text] [Related]
8. Peripheral blood mononuclear phagocytes from patients with chronic periodontitis are primed for osteoclast formation.
Herrera BS; Bastos AS; Coimbra LS; Teixeira SA; Rossa C; Van Dyke TE; Muscara MN; Spolidorio LC
J Periodontol; 2014 Apr; 85(4):e72-81. PubMed ID: 24059638
[TBL] [Abstract][Full Text] [Related]
9. Knockout of the murine prostaglandin EP2 receptor impairs osteoclastogenesis in vitro.
Li X; Okada Y; Pilbeam CC; Lorenzo JA; Kennedy CR; Breyer RM; Raisz LG
Endocrinology; 2000 Jun; 141(6):2054-61. PubMed ID: 10830290
[TBL] [Abstract][Full Text] [Related]
10. Lipopolysaccharide from Prevotella nigrescens stimulates osteoclastogenesis in cocultures of bone marrow mononuclear cells and primary osteoblasts.
Chung YH; Chang EJ; Kim SJ; Kim HH; Kim HM; Lee SB; Ko JS
J Periodontal Res; 2006 Aug; 41(4):288-96. PubMed ID: 16827722
[TBL] [Abstract][Full Text] [Related]
11. Aminothiazoles inhibit osteoclastogenesis and PGE
Kats A; Gerasimcik N; Näreoja T; Nederberg J; Grenlöv S; Lagnöhed E; Desai S; Andersson G; Yucel-Lindberg T
J Cell Mol Med; 2019 Feb; 23(2):1152-1163. PubMed ID: 30506812
[TBL] [Abstract][Full Text] [Related]
12. Effects of selective prostaglandin EP4 receptor antagonist on osteoclast formation and bone resorption in vitro.
Tomita M; Li X; Okada Y; Woodiel FN; Young RN; Pilbeam CC; Raisz LG
Bone; 2002 Jan; 30(1):159-63. PubMed ID: 11792579
[TBL] [Abstract][Full Text] [Related]
13. IL-37 inhibits lipopolysaccharide-induced osteoclast formation and bone resorption in vivo.
Saeed J; Kitaura H; Kimura K; Ishida M; Sugisawa H; Ochi Y; Kishikawa A; Takano-Yamamoto T
Immunol Lett; 2016 Jul; 175():8-15. PubMed ID: 27154248
[TBL] [Abstract][Full Text] [Related]
14. Lipopolysaccharide from Actinobacillus actinomycetemcomitans stimulates production of interleukin-1beta, tumor necrosis factor-alpha, interleukin-6 and interleukin-1 receptor antagonist in human whole blood.
Schytte Blix IJ; Helgeland K; Hvattum E; Lyberg T
J Periodontal Res; 1999 Jan; 34(1):34-40. PubMed ID: 10086884
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-1 receptor antagonist and tumor necrosis factor binding protein decrease osteoclast formation and bone resorption in ovariectomized mice.
Kitazawa R; Kimble RB; Vannice JL; Kung VT; Pacifici R
J Clin Invest; 1994 Dec; 94(6):2397-406. PubMed ID: 7989596
[TBL] [Abstract][Full Text] [Related]
16. Alteration of Homeostasis in Pre-osteoclasts Induced by Aggregatibacter actinomycetemcomitans CDT.
Kawamoto D; Ando-Suguimoto ES; Bueno-Silva B; DiRienzo JM; Mayer MP
Front Cell Infect Microbiol; 2016; 6():33. PubMed ID: 27064424
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of experimental bone resorption and osteoclast formation and survival by 2-aminoethanesulphonic acid.
Koide M; Okahashi N; Tanaka R; Kazuno K; Shibasaki K; Yamazaki Y; Kaneko K; Ueda N; Ohguchi M; Ishihara Y; Noguchi T; Nishihara T
Arch Oral Biol; 1999 Sep; 44(9):711-9. PubMed ID: 10471155
[TBL] [Abstract][Full Text] [Related]
18. Role of prostaglandin in the formation of osteoclasts induced by capsular-like polysaccharide antigen of Actinobacillus actinomycetemcomitans strain Y4.
Ueda N; Nishihara T; Ishihara Y; Amano K; Kuroyanagi T; Noguchi T
Oral Microbiol Immunol; 1995 Apr; 10(2):69-75. PubMed ID: 7675521
[TBL] [Abstract][Full Text] [Related]
19. The role of cyclooxygenase-2 (COX-2) in inflammatory bone resorption.
Coon D; Gulati A; Cowan C; He J
J Endod; 2007 Apr; 33(4):432-6. PubMed ID: 17368333
[TBL] [Abstract][Full Text] [Related]
20. Prostaglandin E2, interleukin 1alpha, and tumor necrosis factor-alpha increase human osteoclast formation and bone resorption in vitro.
Lader CS; Flanagan AM
Endocrinology; 1998 Jul; 139(7):3157-64. PubMed ID: 9645689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
